コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ted system and its application to St. John's wort.
2 rforin, the psychoactive agent in St. John's wort.
3 sed in the perioperative period by St John's wort.
4 Many HIV-infected persons use St. John's wort.
5 varying concentrations to 11.5 degrees Plato wort.
11 n p65 subunit in HT29 treated with St John's Wort and in PC3 treated with thyme might point to the NF
14 ra, garlic, ginkgo, ginseng, kava, St John's wort, and valerian are commonly used herbal medications
18 ition and key aroma compounds of barley malt wort beverages produced from fermentation using six lact
19 rmal decarboxylation of cinnamic acid during wort boiling or by enzymatic decarboxylation during ferm
22 bonitrile, or the herbal medicine, St John's wort, cholesterol precipitation was prevented by increas
24 PI3K) at reperfusion using LY or Wortmannin (Wort) during the first 15 minutes of reperfusion complet
25 herbal supplements (ginkgo biloba, St John's wort, echinacea, ginseng, garlic, saw palmetto, kava kav
26 andomly assigned to receive either St John's wort extract (n = 98; 900 mg/d for 4 weeks, increased to
29 The importance of free fatty acids (FFAs) in wort has been known for a long time because of their inf
33 tonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhi
34 rpurea), ginseng (Panax ginseng), St John' s wort (Hypericum perforatum), and kava (Piper methysticum
35 y acids, S-adenosyl-L-methionine, St. John's wort [Hypericum perforatum]), exercise, and second-gener
36 when these drugs are combined with St John's wort; induction of mania in depressed patients who mix a
42 s that long-term administration of St John's wort may result in diminished clinical effectiveness or
43 al trials have been conducted with St John's wort, most have significant flaws in design and do not e
46 cond+LY, P<0.01; 56.2+/-10.1% with Postcond+ Wort; P<0.01), suggesting that Postcond protects the hea
47 d to a more traditional mash in terms of the wort quality produced (laboratory scale) from five unmal
50 glycerol) during the fermentation process in wort samples by amperometric enzymatic biosensors develo
54 nteresting parameters of beta-glucan in beer wort, such as the molecular weight averages, fraction de
55 given the probe drugs along with 1 St John's wort tablet to establish postadministration CYP activity
56 curred with greater frequency with St John's wort than placebo (39/95 [41%] vs 25/100 [25%], respecti
57 ness was significantly higher with St John's wort than with placebo (P =.02), but the rates were very
58 nephrine reuptake inhibitors, and St. John's wort) that reported clinical outcomes were selected.
59 ermine and characterize beta-glucans in beer wort using size exclusion chromatography coupled with a
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。